Holen Sie sich die Stockscreener-App
17.20
0.35%
-0.06
Handel nachbörslich:
17.19
-0.010
-0.06%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt KVUE?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$17.26
Offen:
$17.2
24-Stunden-Volumen:
57.37M
Relative Volume:
1.42
Marktkapitalisierung:
$32.95B
Einnahmen:
$15.01B
Nettoeinkommen (Verlust:
$1.43B
KGV:
23.12
EPS:
0.744
Netto-Cashflow:
$1.63B
1W Leistung:
+2.20%
1M Leistung:
-0.29%
6M Leistung:
-21.28%
1J Leistung:
-18.83%
1-Tages-Spanne:
$17.06
$17.29
1-Wochen-Bereich:
$16.84
$17.41
52-Wochen-Spanne:
$14.02
$25.17
Kenvue Inc Stock (KVUE) Company Profile
Firmenname
Kenvue Inc
Sektor
Telefon
908-874-1200
Adresse
1 KENVUE WAY, SUMMIT
Vergleichen Sie KVUE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
17.20 | 33.07B | 15.01B | 1.43B | 1.63B | 0.744 |
|
PG
Procter Gamble Co
|
144.53 | 337.96B | 84.93B | 16.86B | 14.94B | 6.8506 |
|
UL
Unilever Plc Adr
|
64.51 | 140.02B | 64.99B | 6.71B | 6.53B | 2.74 |
|
CL
Colgate Palmolive Co
|
84.52 | 67.98B | 20.10B | 3.04B | 3.44B | 3.569 |
|
EL
Estee Lauder Cos Inc
|
115.05 | 41.68B | 14.42B | -930.00M | 1.05B | -2.5832 |
|
KMB
Kimberly Clark Corp
|
99.32 | 33.33B | 18.08B | 1.81B | 1.67B | 5.904 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-29 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2025-09-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2025-04-10 | Eingeleitet | Redburn Atlantic | Neutral |
| 2025-03-24 | Eingeleitet | Evercore ISI | In-line |
| 2025-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-09-24 | Eingeleitet | Jefferies | Buy |
| 2024-09-24 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-05-28 | Fortgesetzt | Citigroup | Neutral |
| 2024-04-11 | Eingeleitet | Bernstein | Underperform |
| 2024-04-03 | Eingeleitet | William Blair | Mkt Perform |
| 2024-03-01 | Fortgesetzt | Goldman | Neutral |
| 2023-11-17 | Eingeleitet | Piper Sandler | Neutral |
| 2023-09-11 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-09-07 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-09-06 | Eingeleitet | Argus | Hold |
| 2023-08-24 | Hochstufung | Goldman | Neutral → Buy |
| 2023-07-25 | Eingeleitet | Edward Jones | Buy |
| 2023-06-01 | Eingeleitet | HSBC Securities | Hold |
| 2023-05-30 | Eingeleitet | BofA Securities | Buy |
| 2023-05-30 | Eingeleitet | Citigroup | Neutral |
| 2023-05-30 | Eingeleitet | Deutsche Bank | Hold |
| 2023-05-30 | Eingeleitet | Exane BNP Paribas | Neutral |
| 2023-05-30 | Eingeleitet | Goldman | Neutral |
| 2023-05-30 | Eingeleitet | JP Morgan | Overweight |
| 2023-05-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-05-30 | Eingeleitet | UBS | Neutral |
Alle ansehen
Kenvue Inc Aktie (KVUE) Neueste Nachrichten
Massachusetts Financial Services Co. MA Sells 3,862,828 Shares of Kenvue Inc. $KVUE - MarketBeat
Published on: 2026-01-19 01:22:15 - baoquankhu1.vn
Kenvue stock has a new catalyst: ISS backs Kimberly-Clark merger ahead of Jan. 29 vote - TechStock²
Tylenol Pregnancy Study Contradicts Trump Claims on Autism Link - Bloomberg.com
Kenvue's Study Finds No Autism Link with Acetaminophen Use During Pregnancy - Intellectia AI
No link between autism and Tylenol: new study (KVUE:NYSE) - Seeking Alpha
Kenvue stock: ISS backs Kimberly-Clark deal as lawsuit filings add pressure ahead of vote - TechStock²
Kenvue Inc. $KVUE Shares Sold by SG Americas Securities LLC - MarketBeat
Kenvue Inc. $KVUE Shares Purchased by Arlington Partners LLC - MarketBeat
Tylenol pregnancy study contradicts Trump's claims on link with autism - Business Standard
The New York Stock Exchange | NYSE - NYSE
Kenvue Supplements Proxy Disclosures Ahead of Merger Vote - TipRanks
KIMBERLY CLARK CORP Announces Merger with Kenvue - TradingView — Track All Markets
Lobbying Update: $60,000 of KENVUE INC. lobbying was just disclosed - Quiver Quantitative
ISS Recommends Approval of Kimberly-Clark's $49B Kenvue Acquisition - Intellectia AI
ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal | Business Information & News | FE - Westlaw Today
ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal - MSN
TD Private Client Wealth LLC Reduces Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Trading Systems Reacting to (KVUE) Volatility - Stock Traders Daily
Kenvue stock is up today — here’s what the Kimberly-Clark deal is worth now - TechStock²
Assessing Kenvue (KVUE) Valuation As Short Term Share Price Momentum Improves - Yahoo Finance
Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching - TechStock²
Nisa Investment Advisors LLC Sells 66,610 Shares of Kenvue Inc. $KVUE - MarketBeat
RBC Capital Sticks to Their Hold Rating for Kenvue, Inc. (KVUE) - The Globe and Mail
Insider Sell: Can Kenvue Inc stock continue upward trend2025 Volume Leaders & Safe Capital Growth Tips - moha.gov.vn
Kenvue (NYSE: KVUE) outlines Kimberly-Clark merger proxy and risks - Stock Titan
2 No-Brainer Dividend Stocks to Buy Right Now - The Motley Fool
ETF Watch: Can Kenvue Inc expand into new marketsJuly 2025 Breakouts & Fast Momentum Entry Tips - baoquankhu1.vn
Momentum Shift: Is Kenvue Inc a cyclical or defensive stockJuly 2025 News Drivers & Low Risk Entry Point Guides - baoquankhu1.vn
Sumitomo Mitsui DS Asset Management Company Ltd Increases Stock Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock lags Kimberly-Clark offer value as deal vote and earnings line up - TechStock²
Alley Investment Management Company LLC Sells 123,556 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue faces class action over Johnson’s baby oil labeling - Global Cosmetics News
Kenvue stock (KVUE) ends week lower as Jan. 29 Kimberly-Clark deal vote nears - TechStock²
Park Avenue Securities LLC Sells 96,606 Shares of Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark Strikes $40 Billion Deal for Tylenol Maker Kenvue - MSN
Kimberly-Clark will buy Tylenol maker Kenvue in a $48.7 billion deal - MSN
Kenvue stock countdown: Jan. 29 merger vote looms as KVUE deal spread stays jumpy - TechStock²
Kimberly-Clark And Kenvue Merger: Great Value Based On Combined Financials (NYSE:KVUE) - Seeking Alpha
Kenvue stock: Options memo spotlights Jan. 29 vote on Kimberly-Clark deal - TechStock²
Kenvue board names Kirk Perry as CEO on permanent basis - MSN
Earnings Preview: Anticipating Kenvue’s Upcoming Results - Bitget
Kenvue Is Considering Selling Some Brands, Reuters Reports - MSN
Kenvue’s winter skin care strategy: Merging ingredient innovation and digital personalization - Personal Care Insights
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Earnings Preview: What to Expect From Kenvue’s Report - Barchart.com
Lecap Asset Management Ltd. Acquires Shares of 60,290 Kenvue Inc. $KVUE - MarketBeat
Kenvue (NYSE:KVUE) Shares Steady Within NYSE Composite Index - Kalkine Media
KLP Kapitalforvaltning AS Has $15.07 Million Stake in Kenvue Inc. $KVUE - MarketBeat
8 agency reviews to know about: IBM, Kenvue, Papa John's, Reese's - Ad Age
Kenvue Appoints Madhav Nayak as Vice President and CMO for Asia-Pacific - Elets CIO
Finanzdaten der Kenvue Inc-Aktie (KVUE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):